Concepedia

Publication | Open Access

Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis

DOIFull Paper Access

10

Citations

29

References

2023

Year

Jingzhong Ouyang, Zhengzheng Wang, Kun Yuan, Yi Yang, Yanzhao Zhou, Qingjun Li, Nanmu Yang, Haitao Zhao, Hong Zhao, Jinxue Zhou
Journal of Hepatocellular Carcinoma

Abstract

Postoperative adjuvant lenvatinib plus PD-1 antibody significantly improved RFS in patients with HCC at high risks of recurrence with acceptable safeties.

References

YearCitations

Page 1